Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
14.68
-0.28 (-1.87%)
Mar 20, 2026, 9:36 AM EDT - Market open
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $1.28 billion as of March 20, 2026. Its market cap has increased by 310.54% in one year.
Market Cap
1.28B
Enterprise Value
802.62M
1-Year Change
310.54%
Ranking
Category
Stock Price
$14.68
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $1.28B, a decrease of -28.70%. That is a compound annual growth rate of -6.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 1.27B | -35.45% |
| Dec 31, 2025 | 1.97B | 357.26% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palvella Therapeutics | 1.36B |
| MBX Biosciences | 1.35B |
| Zenas BioPharma | 1.35B |
| Biohaven | 1.35B |
| Ardelyx | 1.34B |
| AtaiBeckley | 1.30B |
| Taysha Gene Therapies | 1.30B |
| Vir Biotechnology | 1.30B |